# Marriott International Inc: financial statements, quarterly

MAR · Nasdaq · CIK 1048286 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mar.md) · [Financials](/companies/mar/financials.md) · [Filings](/companies/mar/filings.md) · [Insiders](/companies/mar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,928](/filings/0001628280-24-044884.md) | [6,095 d](/filings/0001048286-26-000007.md) | [5,977](/filings/0001628280-25-022485.md) | [6,439](/filings/0001048286-25-000006.md) | [6,255](/filings/0001048286-25-000013.md) | [6,429 d](/filings/0001048286-26-000007.md) | [6,263](/filings/0001048286-26-000014.md) | [6,744](/filings/0001048286-26-000035.md) | [6,489](/filings/0001048286-25-000013.md) | [6,690 d](/filings/0001048286-26-000007.md) | [6,654](/filings/0001048286-26-000014.md) | [7,071](/filings/0001048286-26-000035.md) |
| Operating income | $m | [1,099](/filings/0001628280-24-044884.md) | [718 d](/filings/0001048286-26-000007.md) | [876](/filings/0001628280-25-022485.md) | [1,195](/filings/0001048286-25-000006.md) | [944](/filings/0001048286-25-000013.md) | [752 d](/filings/0001048286-26-000007.md) | [948](/filings/0001048286-26-000014.md) | [1,236](/filings/0001048286-26-000035.md) | [1,180](/filings/0001048286-25-000013.md) | [777 d](/filings/0001048286-26-000007.md) | [1,064](/filings/0001048286-26-000014.md) | [1,229](/filings/0001048286-26-000035.md) |
| Interest expense | $m | [146](/filings/0001628280-23-036256.md) | [153 d](/filings/0001628280-24-004372.md) | [163](/filings/0001628280-24-019494.md) | [173](/filings/0001048286-25-000006.md) | [179](/filings/0001048286-25-000013.md) | [180 d](/filings/0001048286-26-000007.md) | [192](/filings/0001048286-26-000014.md) | [203](/filings/0001048286-26-000035.md) | [206](/filings/0001048286-25-000013.md) | [208 d](/filings/0001048286-26-000007.md) | [214](/filings/0001048286-26-000014.md) | [221](/filings/0001048286-26-000035.md) |
| Income tax | $m | [237](/filings/0001628280-24-044884.md) | [(267) d](/filings/0001048286-26-000007.md) | [163](/filings/0001628280-25-022485.md) | [268](/filings/0001048286-25-000006.md) | [202](/filings/0001048286-25-000013.md) | [143 d](/filings/0001048286-26-000007.md) | [99.0](/filings/0001048286-26-000014.md) | [291](/filings/0001048286-26-000035.md) | [266](/filings/0001048286-25-000013.md) | [137 d](/filings/0001048286-26-000007.md) | [210](/filings/0001048286-26-000014.md) | [278](/filings/0001048286-26-000035.md) |
| Net income | $m | [752](/filings/0001628280-24-044884.md) | [848 d](/filings/0001048286-26-000007.md) | [564](/filings/0001048286-25-000013.md) | [772](/filings/0001048286-25-000013.md) | [584](/filings/0001048286-25-000013.md) | [455 d](/filings/0001048286-26-000007.md) | [665](/filings/0001048286-26-000035.md) | [763](/filings/0001048286-26-000035.md) | [728](/filings/0001048286-25-000013.md) | [445 d](/filings/0001048286-26-000007.md) | [648](/filings/0001048286-26-000035.md) | [766](/filings/0001048286-26-000035.md) |
| Diluted EPS | $ per share | [2.51](/filings/0001628280-24-044884.md) | not reported | [1.93](/filings/0001628280-25-022485.md) | [2.69](/filings/0001048286-25-000006.md) | [2.07](/filings/0001048286-25-000013.md) | not reported | [2.39](/filings/0001048286-26-000014.md) | [2.78](/filings/0001048286-26-000035.md) | [2.67](/filings/0001048286-25-000013.md) | not reported | [2.43](/filings/0001048286-26-000014.md) | [2.90](/filings/0001048286-26-000035.md) |
| Basic EPS | $ per share | [2.52](/filings/0001628280-24-044884.md) | not reported | [1.94](/filings/0001628280-25-022485.md) | [2.70](/filings/0001048286-25-000006.md) | [2.08](/filings/0001048286-25-000013.md) | not reported | [2.40](/filings/0001048286-26-000014.md) | [2.78](/filings/0001048286-26-000035.md) | [2.68](/filings/0001048286-25-000013.md) | not reported | [2.44](/filings/0001048286-26-000014.md) | [2.90](/filings/0001048286-26-000035.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001628280-23-036256.md) | [0.3](/filings/0001628280-25-004818.md) | [0.4](/filings/0001628280-24-019494.md) | [0.3](/filings/0001628280-24-033679.md) | [0.4](/filings/0001628280-24-044884.md) | [0.4](/filings/0001048286-26-000007.md) | [0.5](/filings/0001628280-25-022485.md) | [0.7](/filings/0001048286-25-000006.md) | [0.7](/filings/0001048286-25-000013.md) | [0.4](/filings/0001048286-26-000035.md) | [0.5](/filings/0001048286-26-000014.md) | [0.5](/filings/0001048286-26-000035.md) |
| Current assets | $bn | [3.7](/filings/0001628280-23-036256.md) | [3.3](/filings/0001628280-25-004818.md) | [3.5](/filings/0001628280-24-019494.md) | [3.5](/filings/0001628280-24-033679.md) | [3.6](/filings/0001628280-24-044884.md) | [3.5](/filings/0001048286-26-000007.md) | [3.7](/filings/0001628280-25-022485.md) | [4.0](/filings/0001048286-25-000006.md) | [4.1](/filings/0001048286-25-000013.md) | [3.6](/filings/0001048286-26-000035.md) | [3.9](/filings/0001048286-26-000014.md) | [4.2](/filings/0001048286-26-000035.md) |
| Total assets | $bn | [25.3](/filings/0001628280-23-036256.md) | [25.7](/filings/0001628280-25-004818.md) | [25.8](/filings/0001628280-24-019494.md) | [25.7](/filings/0001628280-24-033679.md) | [26.2](/filings/0001628280-24-044884.md) | [26.2](/filings/0001048286-26-000007.md) | [26.7](/filings/0001628280-25-022485.md) | [27.3](/filings/0001048286-25-000006.md) | [27.8](/filings/0001048286-25-000013.md) | [27.5](/filings/0001048286-26-000035.md) | [27.9](/filings/0001048286-26-000014.md) | [28.1](/filings/0001048286-26-000035.md) |
| Current liabilities | $bn | [7.7](/filings/0001628280-23-036256.md) | [7.8](/filings/0001628280-25-004818.md) | [8.2](/filings/0001628280-24-019494.md) | [8.3](/filings/0001628280-24-033679.md) | [8.5](/filings/0001628280-24-044884.md) | [8.6](/filings/0001048286-26-000007.md) | [8.3](/filings/0001628280-25-022485.md) | [8.2](/filings/0001048286-25-000006.md) | [8.8](/filings/0001048286-25-000013.md) | [8.4](/filings/0001048286-26-000035.md) | [8.5](/filings/0001048286-26-000014.md) | [7.9](/filings/0001048286-26-000035.md) |
| Long-term debt | $bn | [0.1](/filings/0001628280-23-036256.md) | [0.1](/filings/0001628280-25-004818.md) | [0.1](/filings/0001628280-24-019494.md) | [0.1](/filings/0001628280-24-033679.md) | [0.1](/filings/0001628280-24-044884.md) | [0.1](/filings/0001048286-26-000007.md) | [0.0](/filings/0001628280-25-022485.md) | [0.0](/filings/0001048286-25-000006.md) | [0.0](/filings/0001048286-25-000013.md) | [0.0](/filings/0001048286-26-000035.md) | [0.0](/filings/0001048286-26-000014.md) | [0.0](/filings/0001048286-26-000035.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(0.7)](/filings/0001628280-24-044884.md) | [(0.7)](/filings/0001048286-26-000007.md) | [(1.6)](/filings/0001048286-25-000013.md) | [(2.1)](/filings/0001048286-25-000013.md) | [(2.4)](/filings/0001048286-25-000013.md) | [(3.0)](/filings/0001048286-26-000035.md) | [(3.2)](/filings/0001048286-26-000035.md) | [(3.0)](/filings/0001048286-26-000035.md) | [(3.1)](/filings/0001048286-25-000013.md) | [(3.8)](/filings/0001048286-26-000035.md) | [(4.1)](/filings/0001048286-26-000035.md) | [(4.5)](/filings/0001048286-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [881 d](/filings/0001628280-24-044884.md) | [751 d](/filings/0001048286-26-000007.md) | [779](/filings/0001628280-25-022485.md) | [772 d](/filings/0001048286-25-000006.md) | [880 d](/filings/0001048286-25-000013.md) | [318 d](/filings/0001048286-26-000007.md) | [647](/filings/0001048286-26-000014.md) | [643 d](/filings/0001048286-26-000035.md) | [1,093 d](/filings/0001048286-25-000013.md) | [829 d](/filings/0001048286-26-000007.md) | [858](/filings/0001048286-26-000014.md) | [948 d](/filings/0001048286-26-000035.md) |
| Capital expenditure | $m | [124 d](/filings/0001628280-24-044884.md) | [134 d](/filings/0001628280-25-004818.md) | [109](/filings/0001628280-25-022485.md) | [125 d](/filings/0001048286-25-000006.md) | [174 d](/filings/0001048286-25-000013.md) | [342 d](/filings/0001628280-25-004818.md) | [135](/filings/0001048286-26-000014.md) | [155 d](/filings/0001048286-26-000035.md) | [142 d](/filings/0001048286-25-000013.md) | [172 d](/filings/0001048286-26-000007.md) | [130](/filings/0001048286-26-000014.md) | [152 d](/filings/0001048286-26-000035.md) |
| Dividends paid | $m | [154 d](/filings/0001628280-24-044884.md) | [152 d](/filings/0001048286-26-000007.md) | [151](/filings/0001628280-25-022485.md) | [179 d](/filings/0001048286-25-000006.md) | [176 d](/filings/0001048286-25-000013.md) | [176 d](/filings/0001048286-26-000007.md) | [174](/filings/0001048286-26-000014.md) | [183 d](/filings/0001048286-26-000035.md) | [182 d](/filings/0001048286-25-000013.md) | [179 d](/filings/0001048286-26-000007.md) | [178](/filings/0001048286-26-000014.md) | [192 d](/filings/0001048286-26-000035.md) |
| Share repurchases | $m | [942 d](/filings/0001628280-24-044884.md) | [965 d](/filings/0001048286-26-000007.md) | [1,144](/filings/0001628280-25-022485.md) | [1,012 d](/filings/0001048286-25-000006.md) | [1,020 d](/filings/0001048286-25-000013.md) | [586 d](/filings/0001048286-26-000007.md) | [751](/filings/0001048286-26-000014.md) | [749 d](/filings/0001048286-26-000035.md) | [800 d](/filings/0001048286-25-000013.md) | [1,000 d](/filings/0001048286-26-000007.md) | [700](/filings/0001048286-26-000014.md) | [1,119 d](/filings/0001048286-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [326](/filings/0001628280-23-036256.md) | [311](/filings/0001628280-24-019494.md) | [305](/filings/0001628280-24-033679.md) | [300](/filings/0001628280-24-044884.md) | [292](/filings/0001628280-25-022485.md) | [287](/filings/0001048286-25-000006.md) | [282](/filings/0001048286-25-000013.md) | [278](/filings/0001048286-26-000014.md) | [275](/filings/0001048286-26-000035.md) | [273](/filings/0001048286-25-000013.md) | [267](/filings/0001048286-26-000014.md) | [265](/filings/0001048286-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 260,766,288 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001048286-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.